ClinicalTrials.gg
Sign In

Arteriovenous Fistula clinical trials

The registry lists 248 studies for Arteriovenous Fistula across more than 10 countries. 44 are recruiting or about to start. 150 of them are mainly about Arteriovenous Fistula (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Arteriovenous Fistula studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
126
Status unknown
37
Recruiting
27
Not yet recruiting
17
Terminated
16
Active, not recruiting
14

Phase

Phase 2
14
Phase 3
11
Phase 4
8
Phase 1
5
Early Phase 1
1

Where

United States
60
Turkey
22
France
21
China
20
United Kingdom
13
Singapore
11

Who runs them

C. R. Bard (10) · Assiut University (9) · Singapore General Hospital (7) · National Taiwan University Hospital (5) · Proteon Therapeutics (4) · Venova Medical (3) · Medtronic Endovascular (3) · University Hospital, Caen (3)

What is being tested here

Drugs under test in Arteriovenous Fistula studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Apixaban101
Cholesterol-binding protein024
Sirolimus022
Lidocaine012
Benzocaine011
Heparin, Low-Molecular-Weight001
Midazolam001
Sildenafil001
Rosuvastatin001
Vorapaxar001

Drug classes tested here Local anesthetics 4

Coming up

1phase 3 study under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 27 Arteriovenous Fistula studies recruiting now, 13 (48%) set no upper age limit and 4 (15%) stop at 75 or younger. 3 (11%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (7%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
103 (11%)3 (11%)
1824 (89%)24 (89%)
3026 (96%)26 (96%)
4026 (96%)26 (96%)
5026 (96%)26 (96%)
6526 (96%)26 (96%)
7526 (96%)26 (96%)
8519 (70%)19 (70%)

Across all 248 studies, recruiting or not: 11% stop at 75 or younger and 6% at 65; 9% take children; 0% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Arteriovenous Fistula studies take

Of 84 interventional studies with no phase under Arteriovenous Fistula, half reached primary completion within 22 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase22 mo9–43 · 84 studies—21 mo6–43 · 58 studies
Observational27 mo12–45 · 34 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 248. Browse all 248 → or search them.